Botensilimab Uses, Dosage, Side Effects and more
Botensilimab is under investigation in clinical trial NCT03860272 (Fc-engineered Anti-ctla-4 Monoclonal Antibody in Advanced Cancer).
| Trade Name | Botensilimab |
| Generic | Botensilimab |
| Botensilimab Other Names | Botensilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
